Light therapy for fungal eye infection
Part of Eyes & vision clinical trials.
This study tests a new light-based treatment for a rare fungal infection of the eye (Fusarium keratitis) that can cause vision loss. It aims to see if this therapy can fight the infection and help preserve or improve your vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed fungal eye infection caused by Fusarium fungus.
- You must be 18 years or older.
- Your vision loss must be moderate to severe, ranging from 20/40 to 20/400.
- Your cornea (the clear front part of your eye) must be thick enough as measured by a special scan.
- You must be able to understand and commit to follow-up visits.
- You cannot have certain other eye infections, recent eye surgery, or a history of corneal transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This trial tests a new treatment for people who still have eye inflammation after 1 month of standard treatment for a parasitic eye infection (acanthamoeba keratitis). It aims to find a better way to control the infection and reduce inflammation.
This trial studies a light-guided eye treatment in people with generalized inherited retinal disease (a genetic cause of vision loss). It aims to see whether the approach works safely and can improve function for people whose vision is already significantly reduced.
This trial studies ways to prevent worsening vision caused by radiation damage to the retina after plaque brachytherapy for uveal melanoma. You may be randomly assigned to a medication injection, a steroid implant, or observation to see which approach best protects vision.
This trial tests a new eye drop called IVIEW-1201 to see if it works as well as the current standard treatment for fungal keratitis, a serious infection of the cornea. If you have a fungal eye infection confirmed by a lab test and have not used antifungal medications in the last two days, you may be able to join.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
Hear when a new Fusarium Keratitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.